The Indian pharmaceutical industry is expanding quickly, and there is a need of regulatory affairs specialists to meet the present demands of companies in the face of international competition. The goal of governments to protect public health has led to the development of a relatively new profession known as regulatory affairs. Pharmaceuticals, veterinary medications, medical gadgets, pesticides, agrochemicals, and cosmetics are among the industries where the government regulates the safety and effectiveness of products. And alternative treatments. The pharmaceutical firms in charge of these drugs discovery, development, testing, clinical trials, production, manufacturing, and marketingItems also want to make sure that they are providing products that are secure and beneficial to the health and welfare of the general public. legislative issuesThe international regulatory bodies and the pharmaceutical businesses are connected via specialists. It is needed that they. Akshay Kaware | Prof. Santosh Waghmare | Dr. Hemant Kamble "Regulatory Affairs in the Pharmacy Curriulum: A Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-6 | Issue-7 , December 2022, URL: https://www.ijtsrd.com/papers/ijtsrd52279.pdf Paper URL: https://www.ijtsrd.com/pharmacy/other/52279/regulatory-affairs-in-the-pharmacy-curriulum-a-review/akshay-kaware
This document provides an overview of regulatory affairs for drugs. It defines key terms like regulatory affairs, dossier, CTD, eCTD, DMF, NDA, ANDA, and INDA. It describes the role of regulatory affairs experts in guiding product development according to regulatory requirements, compiling dossiers for submission, and ensuring post-marketing compliance. The document outlines a 10 step process for regulatory product development and regulatory submission preparation. It also discusses quality management systems for regulatory compliance and the role of regulatory affairs in marketing and advertising compliance.
Contract Research Organisations- CRO in Pharma FieldVINOTH R
The document provides an overview of contract research organizations (CROs). It discusses that CROs were originally formed to help pharmaceutical companies deal with capacity issues and excess demand. CROs now provide a wide range of clinical trial and drug development services to pharmaceutical sponsors. They have become an important partner for both large pharmaceutical firms and smaller biotech companies. However, the Indian CRO industry still faces challenges such as financial issues, a lack of accredited trial sites, and regulatory hurdles.
The document provides an overview of regulatory affairs as a profession, different regulatory bodies, and the Indian pharmaceutical industry. It discusses regulatory affairs roles in ensuring safety and efficacy compliance. It also outlines several major regulatory bodies including US FDA, EU, Health Canada, and others. Finally, it summarizes the current state of the large and growing Indian pharmaceutical industry, which supplies over 20% of global generics and has potential for further growth and innovation.
Pharmaceutical Offshoring Landscape A Syndicated Reportshekhar619
- The pharmaceutical industry is increasingly offshoring R&D activities to countries like India and China to take advantage of lower costs. India captured $125 million in offshored R&D spending in 2008 and China captured $375 million.
- India has become a major destination for clinical trials and data management due to its large, skilled talent pool and lower costs that are 20-30% of developed markets. The market for outsourced clinical trials in India is growing at 31% annually.
- Pharmaceutical companies are establishing facilities in India's Special Economic Zones which provide tax incentives and regulatory benefits to encourage further offshoring and foreign investment in the country.
Interview pharmatutor: Pharmacy Education and Pharmaceutical IndustryBhaswat Chakraborty
The document discusses pharmacy education in India and opportunities for its improvement. It notes that while theoretical education is generally good, practical training varies significantly between institutions. It also notes differences from Western pharmacy programs which are more patient-centric and clinically oriented, while Indian programs focus more on industrial orientation. Overall pharmacy education meets current employer needs but there is room for growth, particularly in clinical and practical training at the undergraduate level.
The Indian pharmaceutical industry is the second largest by volume globally and is a major contributor to India's economy. While Indian pharmaceutical companies initially made their mark through reverse engineering generic drugs, they are now investing more in research and development to develop new drug molecules. However, challenges remain as stricter patent laws have reduced the market for generic drugs and small companies are struggling to meet higher regulatory standards.
The document discusses marketing strategies used by pharmaceutical companies. It notes that companies are shifting from acute therapies to focusing more on chronic therapies that require long-term treatment. This allows companies to build more stable customer bases. The document also outlines some of the challenges companies face, such as increased competition, high costs of research and development, and complex decision-making processes involving doctors, patients, and other stakeholders. It discusses two common business models - the "super core model" involving a small number of highly successful chronic drugs, and the "core model" involving marketing a larger number of acute drugs.
The document discusses marketing strategies used by pharmaceutical companies. It notes that companies are shifting from acute therapies to focusing more on chronic therapies. This represents a long-term strategy change as chronic therapies require doctors to prescribe the same drugs for longer periods. The document also outlines some of the challenges pharmaceutical companies face in marketing to different customers in the supply chain from doctors to patients. It discusses strategies around patents, research and development, and pursuing either a "super core" model focused on a small number of chronic drugs or a "core" model marketing more acute drugs.
This document provides an overview of regulatory affairs for drugs. It defines key terms like regulatory affairs, dossier, CTD, eCTD, DMF, NDA, ANDA, and INDA. It describes the role of regulatory affairs experts in guiding product development according to regulatory requirements, compiling dossiers for submission, and ensuring post-marketing compliance. The document outlines a 10 step process for regulatory product development and regulatory submission preparation. It also discusses quality management systems for regulatory compliance and the role of regulatory affairs in marketing and advertising compliance.
Contract Research Organisations- CRO in Pharma FieldVINOTH R
The document provides an overview of contract research organizations (CROs). It discusses that CROs were originally formed to help pharmaceutical companies deal with capacity issues and excess demand. CROs now provide a wide range of clinical trial and drug development services to pharmaceutical sponsors. They have become an important partner for both large pharmaceutical firms and smaller biotech companies. However, the Indian CRO industry still faces challenges such as financial issues, a lack of accredited trial sites, and regulatory hurdles.
The document provides an overview of regulatory affairs as a profession, different regulatory bodies, and the Indian pharmaceutical industry. It discusses regulatory affairs roles in ensuring safety and efficacy compliance. It also outlines several major regulatory bodies including US FDA, EU, Health Canada, and others. Finally, it summarizes the current state of the large and growing Indian pharmaceutical industry, which supplies over 20% of global generics and has potential for further growth and innovation.
Pharmaceutical Offshoring Landscape A Syndicated Reportshekhar619
- The pharmaceutical industry is increasingly offshoring R&D activities to countries like India and China to take advantage of lower costs. India captured $125 million in offshored R&D spending in 2008 and China captured $375 million.
- India has become a major destination for clinical trials and data management due to its large, skilled talent pool and lower costs that are 20-30% of developed markets. The market for outsourced clinical trials in India is growing at 31% annually.
- Pharmaceutical companies are establishing facilities in India's Special Economic Zones which provide tax incentives and regulatory benefits to encourage further offshoring and foreign investment in the country.
Interview pharmatutor: Pharmacy Education and Pharmaceutical IndustryBhaswat Chakraborty
The document discusses pharmacy education in India and opportunities for its improvement. It notes that while theoretical education is generally good, practical training varies significantly between institutions. It also notes differences from Western pharmacy programs which are more patient-centric and clinically oriented, while Indian programs focus more on industrial orientation. Overall pharmacy education meets current employer needs but there is room for growth, particularly in clinical and practical training at the undergraduate level.
The Indian pharmaceutical industry is the second largest by volume globally and is a major contributor to India's economy. While Indian pharmaceutical companies initially made their mark through reverse engineering generic drugs, they are now investing more in research and development to develop new drug molecules. However, challenges remain as stricter patent laws have reduced the market for generic drugs and small companies are struggling to meet higher regulatory standards.
The document discusses marketing strategies used by pharmaceutical companies. It notes that companies are shifting from acute therapies to focusing more on chronic therapies that require long-term treatment. This allows companies to build more stable customer bases. The document also outlines some of the challenges companies face, such as increased competition, high costs of research and development, and complex decision-making processes involving doctors, patients, and other stakeholders. It discusses two common business models - the "super core model" involving a small number of highly successful chronic drugs, and the "core model" involving marketing a larger number of acute drugs.
The document discusses marketing strategies used by pharmaceutical companies. It notes that companies are shifting from acute therapies to focusing more on chronic therapies. This represents a long-term strategy change as chronic therapies require doctors to prescribe the same drugs for longer periods. The document also outlines some of the challenges pharmaceutical companies face in marketing to different customers in the supply chain from doctors to patients. It discusses strategies around patents, research and development, and pursuing either a "super core" model focused on a small number of chronic drugs or a "core" model marketing more acute drugs.
This document discusses marketing strategies used by pharmaceutical companies. It begins by providing background on the pharmaceutical industry and market in India. It then discusses some of the challenges faced by pharmaceutical companies in their marketing processes. The rest of the document focuses on and compares two main marketing models - the super core model targeting chronic therapies using a pull system, and the core model targeting acute therapies using a push system. It provides details on how each model approaches marketing through medical representatives, customers, and supply chain management.
The document discusses opportunities and challenges for GSK's marketing strategy due to various political, economic, social and technological factors. It analyzes GSK's strengths like focus on R&D and parent synergy, as well as weaknesses like limited liquidity position. Opportunities discussed are launch of new products and growth in healthcare markets like India. Threats include uncertain R&D outcomes and government regulations. The document also discusses trends reshaping the healthcare industry like empowered patients and use of real-world data. Major changes in digital health are driving new opportunities for pharma companies.
Description & functions of drug regulatory affairsCepal & Co.
This document provides an introduction to regulatory affairs and good regulatory practices. It defines regulatory affairs as the interface between the pharmaceutical industry and drug regulatory authorities, and notes that regulatory affairs is involved in all stages of medicine development and post-marketing activities. The document then discusses the roles and responsibilities of regulatory professionals in liaising with health authorities, ensuring regulatory compliance, and managing product life cycles. It also outlines principles of good regulatory practices such as legality, impartiality, consistency, and transparency.
Opportunity analysis of life science tools market in India - A srinivas sash...Srinivas Sashidhar
An analysis of the life science tools market in India and the market opportunity.
Please note this is a proprietary research on my views in a series of srinivas sashidhar's healthcare instinct. Your views and comments are welcome.
I am also open to individual assignments on market consulting in healthcare related markets.
You can follow my blog at https://kchsashi.blogspot.com/
Opportunities of BDS in Pharmaceutical Industries.pptxDr. Manoj Kumbhare
India is the second-largest pharmaceutical market in Asia. ... A BDS graduate can have various job roles available in this sector: Principal Investigator, Co-investigator, Medical Advisor, Drug Developer, Regulatory Affairs Manager or even a Clinical Research Physician.
Career opportunities in the clinical research field are many and varied, with employment settings ranging from pharmaceutical and biotechnology, to medical device companies, contract research organizations, hospitals, educational institutions, independent contractors and more.
Many professionals with a strong science or healthcare related background — such as nurses, pharmacists, medical technologists, physicians and more — are well-positioned to join the clinical research field. Here are 10 career paths in the field.
This document discusses the role and importance of regulatory affairs professionals in the pharmaceutical industry. It notes that regulatory affairs professionals ensure companies comply with relevant laws and regulations, advise on regulatory strategies and requirements, and facilitate the approval and marketing of drugs by communicating with regulatory agencies. Their work is important for developing innovative products and accelerating time to market while ensuring safety, efficacy and compliance.
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...Ajjay Kumar Gupta
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 billion by 2023: Investment Opportunity for Startups and Entrepreneurs, Medications, Drugs and Pharmaceuticals, Cephalexin Monohydrate, Ampicilin Trihydrate, Ibuprofen Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics, Production Schedule, Working Capital Requirement, Plant Layout, Process Flow Sheet, Cost of Project, Projected Balance Sheets, Profitability Ratios, Break Even Analysis
Production of active pharmaceutical ingredients is a highly sophisticated and technically demanding process. The global active pharmaceutical ingredient market is surging due to the increased demand for pharmaceutical drugs, which in turn is driven by aging population, increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular, neurological and infectious diseases among others. The global Active Pharmaceutical Ingredient market for was valued at US$ 12.9 bn in 2014 and is estimated to reach US$ 21.9 billion by 2023 at a CAGR of 6.3% from 2015 to 2023.
See more
https://goo.gl/dwgi0H
https://goo.gl/qRJmnp
https://goo.gl/t2QFiI
Contact us:
Niir Project Consultancy Services
106-E, Kamla Nagar, Opp. Spark Mall,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886, 8800733955
Mobile: +91-9811043595
Website :
http://www.niir.org
http://www.entrepreneurindia.co
Tags
Active Pharmaceutical Ingredients Manufacturing, Active Pharmaceutical Ingredients, API Manufacture in India, API Manufacturing, Manufacturing of Active Pharmaceutical Ingredients, API Manufacturing Industry, API Manufacturing Plant, Active Pharmaceutical Ingredient Manufacture, Manufacture of Active Pharmaceutical Ingredients, Manufacturing of Active Pharmaceutical Ingredients, Active Pharmaceutical Ingredient Manufacturing Plant, Processing of Active Pharmaceutical Ingredient, Active Pharmaceutical Ingredients Plant, Preparation of Active Pharmaceutical Ingredients (API), Active Pharmaceutical Ingredients Industry, Production of Active Pharmaceutical Ingredients (API), Active Pharmaceutical Ingredients Manufacturing Unit, Plans to Set Up API (Active Pharmaceutical Ingredients) Manufacturing Project, Active Pharmaceutical Ingredient Manufacturing Process, Active Pharmaceutical Ingredients Production, Production Process of API, Active Pharmaceutical Ingredient (API) Production, API Manufacturing Process, Business Planning for Active Pharmaceutical Ingredients Manufacturing, Business Plan for Manufacturing Active Pharmaceutical Ingredient, Start Active Pharmaceutical Ingredient (API) Production Business, Plant for Production of Active Pharmaceutical Ingredient
The document discusses the Indian pharmaceutical industry and analyzes the efficiency of firms using data envelopment analysis (DEA). It notes that the industry is undergoing a shift from a process patent to product patent regime, which will impact generic drug production. DEA is used to measure the relative efficiency of 44 listed pharmaceutical companies over 10 years, examining factors like costs, revenues, and growth. The results from the CCR, BCC, and AR DEA models are analyzed to determine if internal efficiencies correlate with firm growth in this dynamic industry environment.
This document provides an overview of the medical device and equipment industry in India. It discusses key aspects of the industry including leading companies, drivers of growth, challenges, and recommendations for the government. The medical device industry in India is valued at $2.5 billion but has significant growth potential. While private and foreign investment is increasing, challenges remain around low penetration, affordability, and developing a robust regulatory system on par with global standards.
The Indian pharmaceutical industry is the third largest in volume and thirteenth largest in value globally. Total healthcare spending in India is expected to grow 20% annually to $280 billion by 2020 from $65 billion currently. The pharmaceutical industry specifically is expected to grow 12.1% annually to $45 billion by 2020. Growth drivers for the industry include rising incomes, health insurance penetration, and cost advantages of manufacturing generics in India. However, the industry faces challenges such as stringent price controls, lack of data protection, competition from other emerging markets, and attracting and retaining talent. The Indian government is taking initiatives to support the industry through R&D funding, tax benefits, and improving infrastructure and logistics networks.
new management trends in biopharmaceuticalsraj kunwar
The document discusses emerging trends in the biopharmaceutical industry in India. It notes that the Indian biotech industry has grown to over $2 billion and biopharma remains the largest contributor. It outlines various management strategies Indian pharmaceutical firms have taken regarding biotechnology, including contract research and entering the biogenerics market. It also discusses problems the sector faces, such as high drug discovery costs and intellectual property protection, and recommendations to address these issues like allowing early phase clinical trials and reforming patent laws. Emerging trends include increasing government support, regulatory reforms, and more international collaboration.
1. Introduction to regulatory affairs (2).pptxMdJubair13
Regulatory affairs plays a crucial role in the pharmaceutical industry and is involved in all stages of drug development as well as after drug approval and marketing. Regulatory affairs professionals ensure that products contribute to public health by controlling safety and efficacy through compliance with regulations. They provide strategic and technical advice throughout development and registration of products with regulatory agencies. The scope of regulatory affairs includes pharmaceuticals, medical devices, diagnostics, biologics, and other health-related products.
Introduction Indian Pharmaceutical market, SWOT analysis, PEST Analysis, Timeline analysis of Sun Pharma, Glaxo Smith Kline, Mankind, CIPLA and Zydus Cadila.
Unique Device Identification and GS1: Defining Elements in the Future of Glob...Loftware
This white paper, as the title suggests, is about new national and international mandates for a global standard to be used
in the Unique Device Identification (UDI) of medical devices and other healthcare products. It examines the global trading
opportunities, on an enormous scale, that can be captured by early adopters or forfeited by default by those who wait,
dismiss the idea, or discount the powerful market and competitive forces that UDI developments are driving. Also offered
is a starting blueprint for regulatory compliance professionals, packaging engineers, C-suite executives and manufacturing experts who agree the time to start meeting the UDI opportunity has clearly arrived.
The document discusses opportunities and challenges facing India's pharmaceutical industry. It notes that as drug patents expire, Indian generic drug producers are well-positioned to expand globally. It also discusses how India is becoming an attractive location for multinational drug companies to outsource research, development, and manufacturing activities due to its scientific expertise and lower costs. Further, India's large population represents a major potential domestic market, though expanding access to medicines is challenging. The industry now has opportunities for both foreign and domestic firms to partner and leverage each other's strengths for mutual benefit.
The document reviews regulatory requirements for submitting dossiers in African countries like Kenya, Uganda, and Tanzania. It finds that a Common Technical Document (CTD) format is critical for dossier submissions across multiple countries. Following the most stringent guidelines of individual African countries can help streamline approval in other target markets in the region.
The document provides a market analysis for an analytics company called AlphaMD to enter the pharmaceutical market in the UAE. It includes a literature review on the pharmaceutical sector in UAE, identifying key parameters and needs of target companies through interviews. Based on a decision matrix, marketing pharmaceutical companies were identified as the top target. Recommendations include providing competitive intelligence and contracting services at affordable prices while maintaining quality. Limitations include lack of financial data from SMEs and limited interviews.
1) Asia-Pacific represents a large potential market for medical devices due to its growing economies, populations, and unmet medical needs. However, the regulatory environment is complex, diverse, and rapidly changing across different countries in the region.
2) To succeed in this environment, companies must stay aware of regulatory changes and have the expertise to comply with different rules. For example, China and South Korea have introduced new approval pathways and requirements that companies must understand.
3) Outsourcing to partners with regulatory expertise and knowledge of different Asian markets can help companies overcome challenges, stay agile in response to changes, and maximize opportunities in the complex Asia-Pacific medical device market.
‘Six Sigma Technique’ A Journey Through its Implementationijtsrd
The manufacturing industries all over the world are facing tough challenges for growth, development and sustainability in today’s competitive environment. They have to achieve apex position by adapting with the global competitive environment by delivering goods and services at low cost, prime quality and better price to increase wealth and consumer satisfaction. Cost Management ensures profit, growth and sustainability of the business with implementation of Continuous Improvement Technique like Six Sigma. This leads to optimize Business performance. The method drives for customer satisfaction, low variation, reduction in waste and cycle time resulting into a competitive advantage over other industries which did not implement it. The main objective of this paper ‘Six Sigma Technique A Journey Through Its Implementation’ is to conceptualize the effectiveness of Six Sigma Technique through the journey of its implementation. Aditi Sunilkumar Ghosalkar "‘Six Sigma Technique’: A Journey Through its Implementation" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64546.pdf Paper Url: https://www.ijtsrd.com/other-scientific-research-area/other/64546/‘six-sigma-technique’-a-journey-through-its-implementation/aditi-sunilkumar-ghosalkar
Edge Computing in Space Enhancing Data Processing and Communication for Space...ijtsrd
Edge computing, a paradigm that involves processing data closer to its source, has gained significant attention for its potential to revolutionize data processing and communication in space missions. With the increasing complexity and data volume generated by modern space missions, traditional centralized computing approaches face challenges related to latency, bandwidth, and security. Edge computing in space, involving on board processing and analysis of data, offers promising solutions to these challenges. This paper explores the concept of edge computing in space, its benefits, applications, and future prospects in enhancing space missions. Manish Verma "Edge Computing in Space: Enhancing Data Processing and Communication for Space Missions" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64541.pdf Paper Url: https://www.ijtsrd.com/computer-science/artificial-intelligence/64541/edge-computing-in-space-enhancing-data-processing-and-communication-for-space-missions/manish-verma
More Related Content
Similar to Regulatory Affairs in the Pharmacy Curriulum A Review
This document discusses marketing strategies used by pharmaceutical companies. It begins by providing background on the pharmaceutical industry and market in India. It then discusses some of the challenges faced by pharmaceutical companies in their marketing processes. The rest of the document focuses on and compares two main marketing models - the super core model targeting chronic therapies using a pull system, and the core model targeting acute therapies using a push system. It provides details on how each model approaches marketing through medical representatives, customers, and supply chain management.
The document discusses opportunities and challenges for GSK's marketing strategy due to various political, economic, social and technological factors. It analyzes GSK's strengths like focus on R&D and parent synergy, as well as weaknesses like limited liquidity position. Opportunities discussed are launch of new products and growth in healthcare markets like India. Threats include uncertain R&D outcomes and government regulations. The document also discusses trends reshaping the healthcare industry like empowered patients and use of real-world data. Major changes in digital health are driving new opportunities for pharma companies.
Description & functions of drug regulatory affairsCepal & Co.
This document provides an introduction to regulatory affairs and good regulatory practices. It defines regulatory affairs as the interface between the pharmaceutical industry and drug regulatory authorities, and notes that regulatory affairs is involved in all stages of medicine development and post-marketing activities. The document then discusses the roles and responsibilities of regulatory professionals in liaising with health authorities, ensuring regulatory compliance, and managing product life cycles. It also outlines principles of good regulatory practices such as legality, impartiality, consistency, and transparency.
Opportunity analysis of life science tools market in India - A srinivas sash...Srinivas Sashidhar
An analysis of the life science tools market in India and the market opportunity.
Please note this is a proprietary research on my views in a series of srinivas sashidhar's healthcare instinct. Your views and comments are welcome.
I am also open to individual assignments on market consulting in healthcare related markets.
You can follow my blog at https://kchsashi.blogspot.com/
Opportunities of BDS in Pharmaceutical Industries.pptxDr. Manoj Kumbhare
India is the second-largest pharmaceutical market in Asia. ... A BDS graduate can have various job roles available in this sector: Principal Investigator, Co-investigator, Medical Advisor, Drug Developer, Regulatory Affairs Manager or even a Clinical Research Physician.
Career opportunities in the clinical research field are many and varied, with employment settings ranging from pharmaceutical and biotechnology, to medical device companies, contract research organizations, hospitals, educational institutions, independent contractors and more.
Many professionals with a strong science or healthcare related background — such as nurses, pharmacists, medical technologists, physicians and more — are well-positioned to join the clinical research field. Here are 10 career paths in the field.
This document discusses the role and importance of regulatory affairs professionals in the pharmaceutical industry. It notes that regulatory affairs professionals ensure companies comply with relevant laws and regulations, advise on regulatory strategies and requirements, and facilitate the approval and marketing of drugs by communicating with regulatory agencies. Their work is important for developing innovative products and accelerating time to market while ensuring safety, efficacy and compliance.
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 b...Ajjay Kumar Gupta
Active Pharma Ingredients (API) - Global Market Estimated to Reach US$ 21.9 billion by 2023: Investment Opportunity for Startups and Entrepreneurs, Medications, Drugs and Pharmaceuticals, Cephalexin Monohydrate, Ampicilin Trihydrate, Ibuprofen Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics, Production Schedule, Working Capital Requirement, Plant Layout, Process Flow Sheet, Cost of Project, Projected Balance Sheets, Profitability Ratios, Break Even Analysis
Production of active pharmaceutical ingredients is a highly sophisticated and technically demanding process. The global active pharmaceutical ingredient market is surging due to the increased demand for pharmaceutical drugs, which in turn is driven by aging population, increasing prevalence of chronic diseases such as cancer, diabetes, cardiovascular, neurological and infectious diseases among others. The global Active Pharmaceutical Ingredient market for was valued at US$ 12.9 bn in 2014 and is estimated to reach US$ 21.9 billion by 2023 at a CAGR of 6.3% from 2015 to 2023.
See more
https://goo.gl/dwgi0H
https://goo.gl/qRJmnp
https://goo.gl/t2QFiI
Contact us:
Niir Project Consultancy Services
106-E, Kamla Nagar, Opp. Spark Mall,
New Delhi-110007, India.
Email: npcs.ei@gmail.com , info@entrepreneurindia.co
Tel: +91-11-23843955, 23845654, 23845886, 8800733955
Mobile: +91-9811043595
Website :
http://www.niir.org
http://www.entrepreneurindia.co
Tags
Active Pharmaceutical Ingredients Manufacturing, Active Pharmaceutical Ingredients, API Manufacture in India, API Manufacturing, Manufacturing of Active Pharmaceutical Ingredients, API Manufacturing Industry, API Manufacturing Plant, Active Pharmaceutical Ingredient Manufacture, Manufacture of Active Pharmaceutical Ingredients, Manufacturing of Active Pharmaceutical Ingredients, Active Pharmaceutical Ingredient Manufacturing Plant, Processing of Active Pharmaceutical Ingredient, Active Pharmaceutical Ingredients Plant, Preparation of Active Pharmaceutical Ingredients (API), Active Pharmaceutical Ingredients Industry, Production of Active Pharmaceutical Ingredients (API), Active Pharmaceutical Ingredients Manufacturing Unit, Plans to Set Up API (Active Pharmaceutical Ingredients) Manufacturing Project, Active Pharmaceutical Ingredient Manufacturing Process, Active Pharmaceutical Ingredients Production, Production Process of API, Active Pharmaceutical Ingredient (API) Production, API Manufacturing Process, Business Planning for Active Pharmaceutical Ingredients Manufacturing, Business Plan for Manufacturing Active Pharmaceutical Ingredient, Start Active Pharmaceutical Ingredient (API) Production Business, Plant for Production of Active Pharmaceutical Ingredient
The document discusses the Indian pharmaceutical industry and analyzes the efficiency of firms using data envelopment analysis (DEA). It notes that the industry is undergoing a shift from a process patent to product patent regime, which will impact generic drug production. DEA is used to measure the relative efficiency of 44 listed pharmaceutical companies over 10 years, examining factors like costs, revenues, and growth. The results from the CCR, BCC, and AR DEA models are analyzed to determine if internal efficiencies correlate with firm growth in this dynamic industry environment.
This document provides an overview of the medical device and equipment industry in India. It discusses key aspects of the industry including leading companies, drivers of growth, challenges, and recommendations for the government. The medical device industry in India is valued at $2.5 billion but has significant growth potential. While private and foreign investment is increasing, challenges remain around low penetration, affordability, and developing a robust regulatory system on par with global standards.
The Indian pharmaceutical industry is the third largest in volume and thirteenth largest in value globally. Total healthcare spending in India is expected to grow 20% annually to $280 billion by 2020 from $65 billion currently. The pharmaceutical industry specifically is expected to grow 12.1% annually to $45 billion by 2020. Growth drivers for the industry include rising incomes, health insurance penetration, and cost advantages of manufacturing generics in India. However, the industry faces challenges such as stringent price controls, lack of data protection, competition from other emerging markets, and attracting and retaining talent. The Indian government is taking initiatives to support the industry through R&D funding, tax benefits, and improving infrastructure and logistics networks.
new management trends in biopharmaceuticalsraj kunwar
The document discusses emerging trends in the biopharmaceutical industry in India. It notes that the Indian biotech industry has grown to over $2 billion and biopharma remains the largest contributor. It outlines various management strategies Indian pharmaceutical firms have taken regarding biotechnology, including contract research and entering the biogenerics market. It also discusses problems the sector faces, such as high drug discovery costs and intellectual property protection, and recommendations to address these issues like allowing early phase clinical trials and reforming patent laws. Emerging trends include increasing government support, regulatory reforms, and more international collaboration.
1. Introduction to regulatory affairs (2).pptxMdJubair13
Regulatory affairs plays a crucial role in the pharmaceutical industry and is involved in all stages of drug development as well as after drug approval and marketing. Regulatory affairs professionals ensure that products contribute to public health by controlling safety and efficacy through compliance with regulations. They provide strategic and technical advice throughout development and registration of products with regulatory agencies. The scope of regulatory affairs includes pharmaceuticals, medical devices, diagnostics, biologics, and other health-related products.
Introduction Indian Pharmaceutical market, SWOT analysis, PEST Analysis, Timeline analysis of Sun Pharma, Glaxo Smith Kline, Mankind, CIPLA and Zydus Cadila.
Unique Device Identification and GS1: Defining Elements in the Future of Glob...Loftware
This white paper, as the title suggests, is about new national and international mandates for a global standard to be used
in the Unique Device Identification (UDI) of medical devices and other healthcare products. It examines the global trading
opportunities, on an enormous scale, that can be captured by early adopters or forfeited by default by those who wait,
dismiss the idea, or discount the powerful market and competitive forces that UDI developments are driving. Also offered
is a starting blueprint for regulatory compliance professionals, packaging engineers, C-suite executives and manufacturing experts who agree the time to start meeting the UDI opportunity has clearly arrived.
The document discusses opportunities and challenges facing India's pharmaceutical industry. It notes that as drug patents expire, Indian generic drug producers are well-positioned to expand globally. It also discusses how India is becoming an attractive location for multinational drug companies to outsource research, development, and manufacturing activities due to its scientific expertise and lower costs. Further, India's large population represents a major potential domestic market, though expanding access to medicines is challenging. The industry now has opportunities for both foreign and domestic firms to partner and leverage each other's strengths for mutual benefit.
The document reviews regulatory requirements for submitting dossiers in African countries like Kenya, Uganda, and Tanzania. It finds that a Common Technical Document (CTD) format is critical for dossier submissions across multiple countries. Following the most stringent guidelines of individual African countries can help streamline approval in other target markets in the region.
The document provides a market analysis for an analytics company called AlphaMD to enter the pharmaceutical market in the UAE. It includes a literature review on the pharmaceutical sector in UAE, identifying key parameters and needs of target companies through interviews. Based on a decision matrix, marketing pharmaceutical companies were identified as the top target. Recommendations include providing competitive intelligence and contracting services at affordable prices while maintaining quality. Limitations include lack of financial data from SMEs and limited interviews.
1) Asia-Pacific represents a large potential market for medical devices due to its growing economies, populations, and unmet medical needs. However, the regulatory environment is complex, diverse, and rapidly changing across different countries in the region.
2) To succeed in this environment, companies must stay aware of regulatory changes and have the expertise to comply with different rules. For example, China and South Korea have introduced new approval pathways and requirements that companies must understand.
3) Outsourcing to partners with regulatory expertise and knowledge of different Asian markets can help companies overcome challenges, stay agile in response to changes, and maximize opportunities in the complex Asia-Pacific medical device market.
Similar to Regulatory Affairs in the Pharmacy Curriulum A Review (20)
‘Six Sigma Technique’ A Journey Through its Implementationijtsrd
The manufacturing industries all over the world are facing tough challenges for growth, development and sustainability in today’s competitive environment. They have to achieve apex position by adapting with the global competitive environment by delivering goods and services at low cost, prime quality and better price to increase wealth and consumer satisfaction. Cost Management ensures profit, growth and sustainability of the business with implementation of Continuous Improvement Technique like Six Sigma. This leads to optimize Business performance. The method drives for customer satisfaction, low variation, reduction in waste and cycle time resulting into a competitive advantage over other industries which did not implement it. The main objective of this paper ‘Six Sigma Technique A Journey Through Its Implementation’ is to conceptualize the effectiveness of Six Sigma Technique through the journey of its implementation. Aditi Sunilkumar Ghosalkar "‘Six Sigma Technique’: A Journey Through its Implementation" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64546.pdf Paper Url: https://www.ijtsrd.com/other-scientific-research-area/other/64546/‘six-sigma-technique’-a-journey-through-its-implementation/aditi-sunilkumar-ghosalkar
Edge Computing in Space Enhancing Data Processing and Communication for Space...ijtsrd
Edge computing, a paradigm that involves processing data closer to its source, has gained significant attention for its potential to revolutionize data processing and communication in space missions. With the increasing complexity and data volume generated by modern space missions, traditional centralized computing approaches face challenges related to latency, bandwidth, and security. Edge computing in space, involving on board processing and analysis of data, offers promising solutions to these challenges. This paper explores the concept of edge computing in space, its benefits, applications, and future prospects in enhancing space missions. Manish Verma "Edge Computing in Space: Enhancing Data Processing and Communication for Space Missions" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64541.pdf Paper Url: https://www.ijtsrd.com/computer-science/artificial-intelligence/64541/edge-computing-in-space-enhancing-data-processing-and-communication-for-space-missions/manish-verma
Dynamics of Communal Politics in 21st Century India Challenges and Prospectsijtsrd
Communal politics in India has evolved through centuries, weaving a complex tapestry shaped by historical legacies, colonial influences, and contemporary socio political transformations. This research comprehensively examines the dynamics of communal politics in 21st century India, emphasizing its historical roots, socio political dynamics, economic implications, challenges, and prospects for mitigation. The historical perspective unravels the intricate interplay of religious identities and power dynamics from ancient civilizations to the impact of colonial rule, providing insights into the evolution of communalism. The socio political dynamics section delves into the contemporary manifestations, exploring the roles of identity politics, socio economic disparities, and globalization. The economic implications section highlights how communal politics intersects with economic issues, perpetuating disparities and influencing resource allocation. Challenges posed by communal politics are scrutinized, revealing multifaceted issues ranging from social fragmentation to threats against democratic values. The prospects for mitigation present a multifaceted approach, incorporating policy interventions, community engagement, and educational initiatives. The paper conducts a comparative analysis with international examples, identifying common patterns such as identity politics and economic disparities. It also examines unique challenges, emphasizing Indias diverse religious landscape, historical legacy, and secular framework. Lessons for effective strategies are drawn from international experiences, offering insights into inclusive policies, interfaith dialogue, media regulation, and global cooperation. By scrutinizing historical epochs, contemporary dynamics, economic implications, and international comparisons, this research provides a comprehensive understanding of communal politics in India. The proposed strategies for mitigation underscore the importance of a holistic approach to foster social harmony, inclusivity, and democratic values. Rose Hossain "Dynamics of Communal Politics in 21st Century India: Challenges and Prospects" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64528.pdf Paper Url: https://www.ijtsrd.com/humanities-and-the-arts/history/64528/dynamics-of-communal-politics-in-21st-century-india-challenges-and-prospects/rose-hossain
Assess Perspective and Knowledge of Healthcare Providers Towards Elehealth in...ijtsrd
Background and Objective Telehealth has become a well known tool for the delivery of health care in Saudi Arabia, and the perspective and knowledge of healthcare providers are influential in the implementation, adoption and advancement of the method. This systematic review was conducted to examine the current literature base regarding telehealth and the related healthcare professional perspective and knowledge in the Kingdom of Saudi Arabia. Materials and Methods This systematic review was conducted by searching 7 databases including, MEDLINE, CINHAL, Web of Science, Scopus, PubMed, PsycINFO, and ProQuest Central. Studies on healthcare practitioners telehealth knowledge and perspectives published in English in Saudi Arabia from 2000 to 2023 were included. Boland directed this comprehensive review. The researchers examined each connected study using the AXIS tool, which evaluates cross sectional systematic reviews. Narrative synthesis was used to summarise and convey the data. Results Out of 1840 search results, 10 studies were included. Positive outlook and limited knowledge among providers were seen across trials. Healthcare professionals like telehealth for its ability to improve quality, access, and delivery, save time and money, and be successful. Age, gender, occupation, and work experience also affect health workers knowledge. In Saudi Arabia, healthcare professionals face inadequate expert assistance, patient privacy, internet connection concerns, lack of training courses, lack of telehealth understanding, and high costs while performing telemedicine. Conclusions Healthcare practitioners telehealth perceptions and knowledge were examined in this systematic study. Its collection of concerned experts different personal attitudes and expertise would help enhance telehealths implementation in Saudi Arabia, develop its healthcare delivery alternative, and eliminate frequent problems. Badriah Mousa I Mulayhi | Dr. Jomin George | Judy Jenkins "Assess Perspective and Knowledge of Healthcare Providers Towards Elehealth in Saudi Arabia: A Systematic Review" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64535.pdf Paper Url: https://www.ijtsrd.com/medicine/other/64535/assess-perspective-and-knowledge-of-healthcare-providers-towards-elehealth-in-saudi-arabia-a-systematic-review/badriah-mousa-i-mulayhi
The Impact of Digital Media on the Decentralization of Power and the Erosion ...ijtsrd
The impact of digital media on the distribution of power and the weakening of traditional gatekeepers has gained considerable attention in recent years. The adoption of digital technologies and the internet has resulted in declining influence and power for traditional gatekeepers such as publishing houses and news organizations. Simultaneously, digital media has facilitated the emergence of new voices and players in the media industry. Digital medias impact on power decentralization and gatekeeper erosion is visible in several ways. One significant aspect is the democratization of information, which enables anyone with an internet connection to publish and share content globally, leading to citizen journalism and bypassing traditional gatekeepers. Another aspect is the disruption of conventional media industry business models, as traditional organizations struggle to adjust to the decrease in advertising revenue and the rise of digital platforms. Alternative business models, such as subscription models and crowdfunding, have become more prevalent, leading to the emergence of new players. Overall, the impact of digital media on the distribution of power and the weakening of traditional gatekeepers has brought about significant changes in the media landscape and the way information is shared. Further research is required to fully comprehend the implications of these changes and their impact on society. Dr. Kusum Lata "The Impact of Digital Media on the Decentralization of Power and the Erosion of Traditional Gatekeepers" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64544.pdf Paper Url: https://www.ijtsrd.com/humanities-and-the-arts/political-science/64544/the-impact-of-digital-media-on-the-decentralization-of-power-and-the-erosion-of-traditional-gatekeepers/dr-kusum-lata
Online Voices, Offline Impact Ambedkars Ideals and Socio Political Inclusion ...ijtsrd
This research investigates the nexus between online discussions on Dr. B.R. Ambedkars ideals and their impact on social inclusion among college students in Gurugram, Haryana. Surveying 240 students from 12 government colleges, findings indicate that 65 actively engage in online discussions, with 80 demonstrating moderate to high awareness of Ambedkars ideals. Statistically significant correlations reveal that higher online engagement correlates with increased awareness p 0.05 and perceived social inclusion. Variations across colleges and a notable effect of college type on perceived social inclusion highlight the influence of contextual factors. Furthermore, the intersectional analysis underscores nuanced differences based on gender, caste, and socio economic status. Dr. Kusum Lata "Online Voices, Offline Impact: Ambedkar's Ideals and Socio-Political Inclusion - A Study of Gurugram District" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64543.pdf Paper Url: https://www.ijtsrd.com/humanities-and-the-arts/political-science/64543/online-voices-offline-impact-ambedkars-ideals-and-sociopolitical-inclusion--a-study-of-gurugram-district/dr-kusum-lata
Problems and Challenges of Agro Entreprenurship A Studyijtsrd
Noting calls for contextualizing Agro entrepreneurs problems and challenges of the agro entrepreneurs and for greater attention to the Role of entrepreneurs in agro entrepreneurship research, we conduct a systematic literature review of extent research in agriculture entrepreneurship to overcome the study objectives of complications of agro entrepreneurs through various factors, Development of agriculture products is a key factor for the overall economic growth of agro entrepreneurs Agro Entrepreneurs produces firsthand large scale employment, utilizes the labor and natural resources, This research outlines the problems of Weather and Soil Erosions, Market price fluctuation, stimulates labor cost problems, reduces concentration of Price volatility, Dependency on Intermediaries, induces Limited Bargaining Power, and Storage and Transportation Costs. This paper mainly devoted to highlight Problems and challenges faced for the sustainable of Agro Entrepreneurs in India. Vinay Prasad B "Problems and Challenges of Agro Entreprenurship - A Study" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64540.pdf Paper Url: https://www.ijtsrd.com/other-scientific-research-area/other/64540/problems-and-challenges-of-agro-entreprenurship--a-study/vinay-prasad-b
Comparative Analysis of Total Corporate Disclosure of Selected IT Companies o...ijtsrd
Disclosure is a process through which a business enterprise communicates with external parties. A corporate disclosure is communication of financial and non financial information of the activities of a business enterprise to the interested entities. Corporate disclosure is done through publishing annual reports. So corporate disclosure through annual reports plays a vital role in the life of all the companies and provides valuable information to investors. The basic objectives of corporate disclosure is to give a true and fair view of companies to the parties related either directly or indirectly like owner, government, creditors, shareholders etc. in the companies act, provisions have been made about mandatory and voluntary disclosure. The IT sector in India is rapidly growing, the trend to invest in the IT sector is rising and employment opportunities in IT sectors are also increasing. Therefore the IT sector is expected to have fair, full and adequate disclosure of all information. Unfair and incomplete disclosure may adversely affect the entire economy. A research study on disclosure practices of IT companies could play an important role in this regard. Hence, the present research study has been done to study and review comparative analysis of total corporate disclosure of selected IT companies of India and to put forward overall findings and suggestions with a view to increase disclosure score of these companies. The researcher hopes that the present research study will be helpful to all selected Companies for improving level of corporate disclosure through annual reports as well as the government, creditors, investors, all business organizations and upcoming researcher for comparative analyses of level of corporate disclosure with special reference to selected IT companies. Dr. Vaibhavi D. Thaker "Comparative Analysis of Total Corporate Disclosure of Selected IT Companies of India" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64539.pdf Paper Url: https://www.ijtsrd.com/other-scientific-research-area/other/64539/comparative-analysis-of-total-corporate-disclosure-of-selected-it-companies-of-india/dr-vaibhavi-d-thaker
The Impact of Educational Background and Professional Training on Human Right...ijtsrd
This study investigated the impact of educational background and professional training on human rights awareness among secondary school teachers in the Marathwada region of Maharashtra, India. The key findings reveal that higher levels of education, particularly a master’s degree, and fields of study related to education, humanities, or social sciences are associated with greater human rights awareness among teachers. Additionally, both pre service teacher training and in service professional development programs focused on human rights education significantly enhance teacher’s knowledge, skills, and competencies in promoting human rights principles in their classrooms. Baig Ameer Bee Mirza Abdul Aziz | Dr. Syed Azaz Ali Amjad Ali "The Impact of Educational Background and Professional Training on Human Rights Awareness among Secondary School Teachers" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64529.pdf Paper Url: https://www.ijtsrd.com/humanities-and-the-arts/education/64529/the-impact-of-educational-background-and-professional-training-on-human-rights-awareness-among-secondary-school-teachers/baig-ameer-bee-mirza-abdul-aziz
A Study on the Effective Teaching Learning Process in English Curriculum at t...ijtsrd
“One Language sets you in a corridor for life. Two languages open every door along the way” Frank Smith English as a foreign language or as a second language has been ruling in India since the period of Lord Macaulay. But the question is how much we teach or learn English properly in our culture. Is there any scope to use English as a language rather than a subject How much we learn or teach English without any interference of mother language specially in the classroom teaching learning scenario in West Bengal By considering all these issues the researcher has attempted in this article to focus on the effective teaching learning process comparing to other traditional strategies in the field of English curriculum at the secondary level to investigate whether they fulfill the present teaching learning requirements or not by examining the validity of the present curriculum of English. The purpose of this study is to focus on the effectiveness of the systematic, scientific, sequential and logical transaction of the course between the teachers and the learners in the perspective of the 5Es programme that is engage, explore, explain, extend and evaluate. Sanchali Mondal | Santinath Sarkar "A Study on the Effective Teaching Learning Process in English Curriculum at the Secondary Level of West Bengal" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd62412.pdf Paper Url: https://www.ijtsrd.com/humanities-and-the-arts/education/62412/a-study-on-the-effective-teaching-learning-process-in-english-curriculum-at-the-secondary-level-of-west-bengal/sanchali-mondal
The Role of Mentoring and Its Influence on the Effectiveness of the Teaching ...ijtsrd
This paper reports on a study which was conducted to investigate the role of mentoring and its influence on the effectiveness of the teaching of Physics in secondary schools in the South West Region of Cameroon. The study adopted the convergent parallel mixed methods design, focusing on respondents in secondary schools in the South West Region of Cameroon. Both quantitative and qualitative data were collected, analysed separately, and the results were compared to see if the findings confirm or disconfirm each other. The quantitative analysis found that majority of the respondents 72 of Physics teachers affirmed that they had more experienced colleagues as mentors to help build their confidence, improve their teaching, and help them improve their effectiveness and efficiency in guiding learners’ achievements. Only 28 of the respondents disagreed with these statements. With majority respondents 72 agreeing with the statements, it implies that in most secondary schools, experienced Physics teachers act as mentors to build teachers’ confidence in teaching and improving students’ learning. The interview qualitative data analysis summarized how secondary school Principals use meetings with mentors and mentees to promote mentorship in the school milieu. This has helped strengthen teachers’ classroom practices in secondary schools in the South West Region of Cameroon. With the results confirming each other, the study recommends that mentoring should focus on helping teachers employ social interactions and instructional practices feedback and clarity in teaching that have direct measurable impact on students’ learning achievements. Andrew Ngeim Sumba | Frederick Ebot Ashu | Peter Agborbechem Tambi "The Role of Mentoring and Its Influence on the Effectiveness of the Teaching of Physics in Secondary Schools in the South West Region of Cameroon" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64524.pdf Paper Url: https://www.ijtsrd.com/management/management-development/64524/the-role-of-mentoring-and-its-influence-on-the-effectiveness-of-the-teaching-of-physics-in-secondary-schools-in-the-south-west-region-of-cameroon/andrew-ngeim-sumba
Design Simulation and Hardware Construction of an Arduino Microcontroller Bas...ijtsrd
This study primarily focuses on the design of a high side buck converter using an Arduino microcontroller. The converter is specifically intended for use in DC DC applications, particularly in standalone solar PV systems where the PV output voltage exceeds the load or battery voltage. To evaluate the performance of the converter, simulation experiments are conducted using Proteus Software. These simulations provide insights into the input and output voltages, currents, powers, and efficiency under different state of charge SoC conditions of a 12V,70Ah rechargeable lead acid battery. Additionally, the hardware design of the converter is implemented, and practical data is collected through operation, monitoring, and recording. By comparing the simulation results with the practical results, the efficiency and performance of the designed converter are assessed. The findings indicate that while the buck converter is suitable for practical use in standalone PV systems, its efficiency is compromised due to a lower output current. Chan Myae Aung | Dr. Ei Mon "Design Simulation and Hardware Construction of an Arduino-Microcontroller Based DC-DC High-Side Buck Converter for Standalone PV System" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64518.pdf Paper Url: https://www.ijtsrd.com/engineering/mechanical-engineering/64518/design-simulation-and-hardware-construction-of-an-arduinomicrocontroller-based-dcdc-highside-buck-converter-for-standalone-pv-system/chan-myae-aung
Sustainable Energy by Paul A. Adekunte | Matthew N. O. Sadiku | Janet O. Sadikuijtsrd
Energy becomes sustainable if it meets the needs of the present without compromising the ability of future generations to meet their own needs. Some of the definitions of sustainable energy include the considerations of environmental aspects such as greenhouse gas emissions, social, and economic aspects such as energy poverty. Generally far more sustainable than fossil fuel are renewable energy sources such as wind, hydroelectric power, solar, and geothermal energy sources. Worthy of note is that some renewable energy projects, like the clearing of forests to produce biofuels, can cause severe environmental damage. The sustainability of nuclear power which is a low carbon source is highly debated because of concerns about radioactive waste, nuclear proliferation, and accidents. The switching from coal to natural gas has environmental benefits, including a lower climate impact, but could lead to delay in switching to more sustainable options. “Carbon capture and storage” can be built into power plants to remove the carbon dioxide CO2 emissions, but this technology is expensive and has rarely been implemented. Leading non renewable energy sources around the world is fossil fuels, coal, petroleum, and natural gas. Nuclear energy is usually considered another non renewable energy source, although nuclear energy itself is a renewable energy source, but the material used in nuclear power plants is not. The paper addresses the issue of sustainable energy, its attendant benefits to the future generation, and humanity in general. Paul A. Adekunte | Matthew N. O. Sadiku | Janet O. Sadiku "Sustainable Energy" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64534.pdf Paper Url: https://www.ijtsrd.com/engineering/electrical-engineering/64534/sustainable-energy/paul-a-adekunte
Concepts for Sudan Survey Act Implementations Executive Regulations and Stand...ijtsrd
This paper aims to outline the executive regulations, survey standards, and specifications required for the implementation of the Sudan Survey Act, and for regulating and organizing all surveying work activities in Sudan. The act has been discussed for more than 5 years. The Land Survey Act was initiated by the Sudan Survey Authority and all official legislations were headed by the Sudan Ministry of Justice till it was issued in 2022. The paper presents conceptual guidelines to be used for the Survey Act implementation and to regulate the survey work practice, standardizing the field surveys, processing, quality control, procedures, and the processes related to survey work carried out by the stakeholders and relevant authorities in Sudan. The conceptual guidelines are meant to improve the quality and harmonization of geospatial data and to aid decision making processes as well as geospatial information systems. The established comprehensive executive regulations will govern and regulate the implementation of the Sudan Survey Geomatics Act in all surveying and mapping practices undertaken by the Sudan Survey Authority SSA and state local survey departments for public or private sector organizations. The targeted standards and specifications include the reference frame, projection, coordinate systems, and the guidelines and specifications that must be followed in the field of survey work, processes, and mapping products. In the last few decades, there has been a growing awareness of the importance of geomatics activities and measurements on the Earths surface in space and time, together with observing and mapping the changes. In such cases, data must be captured promptly, standardized, and obtained with more accuracy and specified in much detail. The paper will also highlight the current situation in Sudan, the degree to which survey standards are used, the problems encountered, and the errors that arise from not using the standards and survey specifications. Kamal A. A. Sami "Concepts for Sudan Survey Act Implementations - Executive Regulations and Standards" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd63484.pdf Paper Url: https://www.ijtsrd.com/engineering/civil-engineering/63484/concepts-for-sudan-survey-act-implementations--executive-regulations-and-standards/kamal-a-a-sami
Towards the Implementation of the Sudan Interpolated Geoid Model Khartoum Sta...ijtsrd
The discussions between ellipsoid and geoid have invoked many researchers during the recent decades, especially during the GNSS technology era, which had witnessed a great deal of development but still geoid undulation requires more investigations. To figure out a solution for Sudans local geoid, this research has tried to intake the possibility of determining the geoid model by following two approaches, gravimetric and geometrical geoid model determination, by making use of GNSS leveling benchmarks at Khartoum state. The Benchmarks are well distributed in the study area, in which, the horizontal coordinates and the height above the ellipsoid have been observed by GNSS while orthometric heights were carried out using precise leveling. The Global Geopotential Model GGM represented in EGM2008 has been exploited to figure out the geoid undulation at the benchmarks in the study area. This is followed by a fitting process, that has been done to suit the geoid undulation data which has been computed using GNSS leveling data and geoid undulation inspired by the EGM2008. Two geoid surfaces were created after the fitting process to ensure that they are identical and both of them could be counted for getting the same geoid undulation with an acceptable accuracy. In this respect, statistical operation played an important role in ensuring the consistency and integrity of the model by applying cross validation techniques splitting the data into training and testing datasets for building the geoid model and testing its eligibility. The geometrical solution for geoid undulation computation has been utilized by applying straightforward equations that facilitate the calculation of the geoid undulation directly through applying statistical techniques for the GNSS leveling data of the study area to get the common equation parameters values that could be utilized to calculate geoid undulation of any position in the study area within the claimed accuracy. Both systems were checked and proved eligible to be used within the study area with acceptable accuracy which may contribute to solving the geoid undulation problem in the Khartoum area, and be further generalized to determine the geoid model over the entire country, and this could be considered in the future, for regional and continental geoid model. Ahmed M. A. Mohammed. | Kamal A. A. Sami "Towards the Implementation of the Sudan Interpolated Geoid Model (Khartoum State Case Study)" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd63483.pdf Paper Url: https://www.ijtsrd.com/engineering/civil-engineering/63483/towards-the-implementation-of-the-sudan-interpolated-geoid-model-khartoum-state-case-study/ahmed-m-a-mohammed
Activating Geospatial Information for Sudans Sustainable Investment Mapijtsrd
Sudan is witnessing an acceleration in the processes of development and transformation in the performance of government institutions to raise the productivity and investment efficiency of the government sector. The development plans and investment opportunities have focused on achieving national goals in various sectors. This paper aims to illuminate the path to the future and provide geospatial data and information to develop the investment climate and environment for all sized businesses, and to bridge the development gap between the Sudan states. The Sudan Survey Authority SSA is the main advisor to the Sudan Government in conducting surveying, mappings, designing, and developing systems related to geospatial data and information. In recent years, SSA made a strategic partnership with the Ministry of Investment to activate Geospatial Information for Sudans Sustainable Investment and in particular, for the preparation and implementation of the Sudan investment map, based on the directives and objectives of the Ministry of Investment MI in Sudan. This paper comes within the framework of activating the efforts of the Ministry of Investment to develop technical investment services by applying techniques adopted by the Ministry and its strategic partners for advancing investment processes in the country. Kamal A. A. Sami "Activating Geospatial Information for Sudan's Sustainable Investment Map" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd63482.pdf Paper Url: https://www.ijtsrd.com/engineering/information-technology/63482/activating-geospatial-information-for-sudans-sustainable-investment-map/kamal-a-a-sami
Educational Unity Embracing Diversity for a Stronger Societyijtsrd
In a rapidly changing global landscape, the importance of education as a unifying force cannot be overstated. This paper explores the crucial role of educational unity in fostering a stronger and more inclusive society through the embrace of diversity. By examining the benefits of diverse learning environments, the paper aims to highlight the positive impact on societal strength. The discussion encompasses various dimensions, from curriculum design to classroom dynamics, and emphasizes the need for educational institutions to become catalysts for unity in diversity. It highlights the need for a paradigm shift in educational policies, curricula, and pedagogical approaches to ensure that they are reflective of the diverse fabric of society. This paper also addresses the challenges associated with implementing inclusive educational practices and offers practical strategies for overcoming barriers. It advocates for collaborative efforts between educational institutions, policymakers, and communities to create a supportive ecosystem that promotes diversity and unity. Mr. Amit Adhikari | Madhumita Teli | Gopal Adhikari "Educational Unity: Embracing Diversity for a Stronger Society" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64525.pdf Paper Url: https://www.ijtsrd.com/humanities-and-the-arts/education/64525/educational-unity-embracing-diversity-for-a-stronger-society/mr-amit-adhikari
Integration of Indian Indigenous Knowledge System in Management Prospects and...ijtsrd
The diversity of indigenous knowledge systems in India is vast and can vary significantly between different communities and regions. Preserving and respecting these knowledge systems is crucial for maintaining cultural heritage, promoting sustainable practices, and fostering cross cultural understanding. In this paper, an overview of the prospects and challenges associated with incorporating Indian indigenous knowledge into management is explored. It is found that IIKS helps in management in many areas like sustainable development, tourism, food security, natural resource management, cultural preservation and innovation, etc. However, IIKS integration with management faces some challenges in the form of a lack of documentation, cultural sensitivity, language barriers legal framework, etc. Savita Lathwal "Integration of Indian Indigenous Knowledge System in Management: Prospects and Challenges" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd63500.pdf Paper Url: https://www.ijtsrd.com/management/accounting-and-finance/63500/integration-of-indian-indigenous-knowledge-system-in-management-prospects-and-challenges/savita-lathwal
DeepMask Transforming Face Mask Identification for Better Pandemic Control in...ijtsrd
The COVID 19 pandemic has highlighted the crucial need of preventive measures, with widespread use of face masks being a key method for slowing the viruss spread. This research investigates face mask identification using deep learning as a technological solution to be reducing the risk of coronavirus transmission. The proposed method uses state of the art convolutional neural networks CNNs and transfer learning to automatically recognize persons who are not wearing masks in a variety of circumstances. We discuss how this strategy improves public health and safety by providing an efficient manner of enforcing mask wearing standards. The report also discusses the obstacles, ethical concerns, and prospective applications of face mask detection systems in the ongoing fight against the pandemic. Dilip Kumar Sharma | Aaditya Yadav "DeepMask: Transforming Face Mask Identification for Better Pandemic Control in the COVID-19 Era" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd64522.pdf Paper Url: https://www.ijtsrd.com/engineering/electronics-and-communication-engineering/64522/deepmask-transforming-face-mask-identification-for-better-pandemic-control-in-the-covid19-era/dilip-kumar-sharma
Streamlining Data Collection eCRF Design and Machine Learningijtsrd
Efficient and accurate data collection is paramount in clinical trials, and the design of Electronic Case Report Forms eCRFs plays a pivotal role in streamlining this process. This paper explores the integration of machine learning techniques in the design and implementation of eCRFs to enhance data collection efficiency. We delve into the synergies between eCRF design principles and machine learning algorithms, aiming to optimize data quality, reduce errors, and expedite the overall data collection process. The application of machine learning in eCRF design brings forth innovative approaches to data validation, anomaly detection, and real time adaptability. This paper discusses the benefits, challenges, and future prospects of leveraging machine learning in eCRF design for streamlined and advanced data collection in clinical trials. Dhanalakshmi D | Vijaya Lakshmi Kannareddy "Streamlining Data Collection: eCRF Design and Machine Learning" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-8 | Issue-1 , February 2024, URL: https://www.ijtsrd.com/papers/ijtsrd63515.pdf Paper Url: https://www.ijtsrd.com/biological-science/biotechnology/63515/streamlining-data-collection-ecrf-design-and-machine-learning/dhanalakshmi-d
Leveraging Generative AI to Drive Nonprofit InnovationTechSoup
In this webinar, participants learned how to utilize Generative AI to streamline operations and elevate member engagement. Amazon Web Service experts provided a customer specific use cases and dived into low/no-code tools that are quick and easy to deploy through Amazon Web Service (AWS.)
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
Beyond Degrees - Empowering the Workforce in the Context of Skills-First.pptxEduSkills OECD
Iván Bornacelly, Policy Analyst at the OECD Centre for Skills, OECD, presents at the webinar 'Tackling job market gaps with a skills-first approach' on 12 June 2024
Temple of Asclepius in Thrace. Excavation resultsKrassimira Luka
The temple and the sanctuary around were dedicated to Asklepios Zmidrenus. This name has been known since 1875 when an inscription dedicated to him was discovered in Rome. The inscription is dated in 227 AD and was left by soldiers originating from the city of Philippopolis (modern Plovdiv).
How to Setup Warehouse & Location in Odoo 17 InventoryCeline George
In this slide, we'll explore how to set up warehouses and locations in Odoo 17 Inventory. This will help us manage our stock effectively, track inventory levels, and streamline warehouse operations.
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
2. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD52279 | Volume – 6 | Issue – 7 | November-December 2022 Page 118
Pharmaceutical Drug Regulatory Affairs: The
person is responsible for knowing the regulatory
requirements for getting new products approved.
They know what commitments the company has
made to the regulatory agencies where the product
has been approved.[7] They also submit annual
reports and supplements to the agencies. Regulatory
Affairs typically communicates with one of the
Centers (e.g., Center for Drug Evaluation and
Research) at the FDA headquarters, rather than the
FDA local district offices. Gimps do not directly
apply to Regulatory Affairs; however, they must
understand and evaluate changes to drug
manufacturing and testing activities to determine if
and when the FDA must be notified.[8] Regulatory
Affairs is a comparatively new profession which has
developed from the desire of governments to protect
public health, by controlling the safety and efficacy of
products in areas including pharmaceuticals,
veterinary medicines, medical devices, pesticides,
agrochemicals, cosmetics and complementary
medicines.[9] The companies responsible for the
discovery, testing, manufacture and marketing of
these products also want to ensure that they supply
products that are safe and make a worthwhile
contribution to public health and welfare. The
Regulatory Affairs department will take part in the
development of the product marketing concepts and is
usually required to approve packaging and advertising
before it is used commercially. Their Regulatory
Affairs (RA) departments must be aware of the
regulatory requirements in all the company’s export
markets.[10] As an added complication, despite
recent international efforts towards harmonization of
requirements, the regulations laid down by different
governments. Therefore great care has to be taken in
drawing up efficient and economical research and
development programs whose results may be used as
widely as possible. Regulatory Affairs professionals,
with their detailed knowledge of the regulations and
guidelines, are frequently called in to advice on such
matters.[11]
Education in Regulatory Affairs: A person involved
in regulatory affairs must be knowledgeable of all
regulations, guidelines, and rules.
Documents. He ought to be well knowledgeable about
a specific regulatory document that was written.[12]
These individuals are the main conduit for
communication between the company and
international regulatory organisations including the
USFDA (Food and Drug Administration of the
United States) and European Drug Regulatory Affairs
Union (EUDRA).
[13] a number
Regulatory Affairs Professional, among other
organisations, Drug Information Association (DIA),
3. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD52279 | Volume – 6 | Issue – 7 | November-December 2022 Page 119
the RAPS Society, and the International and the Food
and Drug Law Institute (FDLI) groups like the
European Society of Regulatory
A major part of giving pertinent information is
affairs.
[14] The programme often consists of introductory a
foundation that describes the development of medical
products, research, development process and the
regulatory oversight of the complex processes. There
are both part-time and full-time courses available for
the subject.[15] Part-time courses are suitable for the
professional who will come across these terms
occasionally where as full-time course is meant for
the professional who intends to make his career in the
regulatory affairs.[16]
Institutions in India offering Regulatory Affairs:
In India huge amount of colleges and universities
throughout offer the course of regulatory affairs. The
course material is also available in the form of online,
distance learning and interactive CDs mode.
Regulatory affairs position is in highest demand and
fastest growing according to the findings from a
recent survey on employment trends in the clinical
trials.[17] A pharmaceutical Regulatory affair (RA) is
a vast area, which cannot be taught just with the help
of books or the course materials. The issues related to
the field are often updated so the professionals find it
challenging to keep abreast with the recent
modifications and inclusions[18]. Importance of
Regulatory Affairs In today’s competitive
environment the reduction of the time taken to reach
the market is critical to a product’s and hence the
company’s success. The proper conduct of its
Regulatory Affairs (RA) activities is therefore of
considerable economic importance for the
company.[19] Inadequate reporting of data may
prevent a timely positive evaluation of a marketing
application. A new drug may have cost manymillions
of pounds, Euros or dollars to develop and even a
three-month delay in bringing it to the market has
considerable financial considerations.[20]
failures to fully report all the available data or the
release of product bearing incorrect labeling, may
easily result in the need for a product recall may lead
to the loss of several millions of units of sales, not to
mention the resulting reduction in confidence of the
investors, health professionals and patients.[21] A
good Regulatory Affairs professional will have a
‘right first time’ approach and will play a very
important part in coordinating scientific Endeavour
with regulatory demands throughout the life of the
product, helping to maximize the cost-effective use of
the company’s resources.[22] The Regulatory Affairs
department is very often the first point of contact
between the government authorities and the company.
The attitudes and actions of the Regulatory Affairs
(RA) professionals will condition the perceptions of
the government officials to the company for better.
[23] The importance of the Regulatory Affairs
function is such that senior Regulatory Affairs (RA)
professionals are increasingly being appointed to
boardroom positions, where they can advise upon and
further influence the strategic decisions of their
companies.[24]
Recent Advancements
Recently, the Govt. of India has constituted a few
autonomous bodies to gauge the standards of
profession of Pharmacy & grade the colleges
accordingly so that the students, parents, employers
and funding agencies have a valid & reliable rating of
the various Pharmacy colleges in the country.[25]
These are:
(1) National Board of Accreditation (NBA) under the
aegis of All India Council for Technical Education.
National Assessment and Accreditation Council
(NAAC) by the University Grants Commission. The
Drug Regulatory Affairs Professional The
pharmaceutical research and development process of
bringing a new drug to the market takes many years;
it is therefore essential that the process be managed
effectively from beginning to end in order to meet the
regulatory requirements and permit a favorable
evaluation of efficacy and safety in the shortest
possible time.[26] The drug regulatory affairs (DRA)
professional plays an important role in every phase of
this process, from developing regulatory strategies
following the discovery of a new chemical entity to
planning post-marketing activities. The main
responsibility of the DRA professional within a
pharmaceutical company is to secure approval of drug
submissions from Health Therapeutic Products
Program (TPP) and to ensure regulatory compliance
of marketed and investigational drugs with the Food
and Drug Act and Regulations and TPP
Guidelines/Policies.[27] In this position, the DRA
professional must possess a proficient scientific
background (B.Sc, M.Sc., Ph.D., M.D. B. Pharm,
M.Pharm or Pharm.D.) and have acquired a thorough
knowledge of Indian regulations as well as
international regulations.[28] Because the regulatory
environment is evolving rapidly toward global
harmonization (several ICH guidelines have now
been adopted by TPP) and mutual recognition
between different health authorities across the world,
it is a major challenge for the DRA professional to
keep abreast of policy changes and determine how
these changes affect the approval process.
Consequently, the importance of DRA in the
4. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD52279 | Volume – 6 | Issue – 7 | November-December 2022 Page 120
development and approval of new drugs has increased
significantly over the last decade.[29] Whether a
submission is filed to the TPP for the conduct of a
clinical trial (Investigational New Drug Submission,
or IND), for the approval to market a new drug (New
Drug Submission, or NDS), for a new indication or
dosage form for a marketed drug (Supplemental NDS,
or S/NDS), or for the maintenance of a marketed
drug's regulatory status, the submission's preparation
entails the close collaboration of a multidisciplinary
team.[30] The DRA professional must actively
participate in discussions and coordinate team
activities to obtain all the necessarydocumentation as
per the current TPP policies and then assess it for
completeness and accuracy. Therefore, the effective
DRA professional must exhibit the organizational and
interpersonal skills of a "team player" and also be
thorough and detail-oriented.[31] The scope of
responsibilities is wide and may vary significantly
according to the organizational structure of the
pharmaceutical company. The responsibilities of
some DRA professionals may focus exclusively on
pharmacovigilance activities or on the electronic
representation of information (electronic
submissions).[32] The common point, however, is
that the DRA professional is the primary liaison
between the sponsor and the TPP. In this capacity, the
individual must possess excellent writing and
communication skills and be an effective negotiator.
This is to ensure that the requests or comments
generated during the submissions review process are
promptly and satisfactorily answered and to negotiate
the most favorable labeling (Product Monograph)
consistent with the sponsor's business objectives.[33]
In line with today's growing technological
developments, knowledge of several computer
applications is essential to effectively fulfill the job
requirements. DRA is a dynamic, rewarding field that
embraces both scientific and legal aspects of drug
development. DRA professionals are dedicated
individuals who take pride in their contribution to
improving the health and quality of life of
peoples.[34]
Responsibility of Regulatory Affairs
Professional’s- The Regulatory Affairs professional’s
job is to keep track of the ever-changing legislation in
all the regions in which the company wishes to
distribute its products. They also advise on the legal
and scientific restraints and requirements, and collect,
collate, and evaluate the scientific data that their
research and development colleagues are
generating.[35] They are responsible for the
presentation of registration documents to regulatory
agencies, and carry out all the subsequent
negotiations necessary to maintain marketing
authorization for the products concerned. They give
strategic and technical advice at the highest level in
their companies, right from the beginning of the
development of a product, making an important
contribution both commercially and scientifically to
the success of a development program and the
company as a whole.[36] It may take anything up to
15 years to develop and launch a new pharmaceutical
product and many problems may arise in the process
of scientific development and because of a changing
regulatory environment.[37] Regulatory affairs (RA)
professionals help the company avoid problems
caused by badly kept records, inappropriate scientific
thinking or poor presentation of data. In most product
areas where regulatory requirements are imposed,
restrictions are also placed upon the claims which can
be made for the product on labelling or in
advertising.[38] List of responsibilities of Regulatory
Affairs Department
1. Keep in touch with international legislation,
guidelines and customer practices
2. Keep up to the date with a company’s product
range
3. Ensure that a company’s products comply with the
current regulations.
4. The Regulatory Affairs professional’s job is to
keep track of the ever-changing legislation in all the
regions in which the company wishes to distribute its
products. They also advise on the legal and scientific
restraints and requirements, and collect, collate, and
evaluate the scientific data that their research and
development colleagues are generating.[39]
5. Formulate regulatory strategy for all appropriate
regulatory submissions for domestic, international
and/or contract projects.
6. Coordinate, prepare and review all appropriate
documents for example dossier and submit them to
regulatory authorities within a specified time frame in
conjugation with the organization.
7. Prepare and review of SOPs related to RA. Review
of BMR, MFR, change control and other relevant
documents.[40]
8. Monitor the progress of all registration submission.
9. Maintain approved applications and the record of
registration fees paid against submission of DMF’s
and other documents.
10.Respond to queries as they arise, and ensure that
registration/ approvalare granted without delay.[41]
11. Impart training to R&D, Pilot plant, ADl and RA.
Team members on current regulatory requirements.
5. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD52279 | Volume – 6 | Issue – 7 | November-December 2022 Page 121
12. Advising their companies on the regulatory
aspects and climate that would affect proposed
activities. i.e. describing the "regulatory climate"
around issues such as the promotion of prescription
drugs and Sarbanes-Oxley compliance.
13. Manage review audit reports and compliance,
regulatory and customer inspections.[42]
14.Regulatory Affairs professionals help the
company avoid problems caused by badly kept
records, inappropriate scientific thinking or poor
presentation of data. In most product areas where
regulatory requirements are imposed, restrictions are
also placed upon the claims which can be made for
the product on labelling or in advertising.
15. Have a duty to provide physicians and other
healthcare professionals with accurate and complete
information about the quality, safety and
effectiveness of the product.
Pharma regulatory affairs jobs: Professionals
working in pharmaceutical regulatory affairs roles
will be required to handle a number of different tasks;
from keeping on top of the latest developments within
the industry to writing product labels and patent
information. As well as collecting and collating large
amounts of information and preparing licensing
submissions, pharma regulatory affairs jobs also
include liaising with doctors and scientists,
conducting clinical trials and negotiating with
regulatory authorities. Workers may also be tasked
with undertaking and managing regulatory
inspections within the company and reviewing
practices when required to meet with new or updated
regulatory requirements.[43] Opportunities for
regulatory affairs consultants offer professionals the
chance to work in a number of fields, which requires
high levels of knowledge of multiple industries. Jobs
in pharma regulatory affairs generally require a
background in the applicable industry, business
knowledge, great oral and written communication,
good attention to detail and strong IT skills. The
international scope of many companies working
within the pharmaceutical industry mean that a
second language is generally desirable, as it previous
work experience within a clinical or pharma setting
Pharma regulatory affairs jobs in India - Asia has
emerged as a strong growth region for the
pharmaceutical industry in recent years, in particular
India which is fast becoming a preferred location for
clinical trials and research and development activities.
The creation of a new product patent system in 2005
was a driver of this growth, which is expected to
increase as the domestic market in India further opens
up.[44] This growth has also helped facilitate an
increasing number of pharma regulatory affairs jobs
in India. A number of companies have set up in the
most populous city in the country, creating a number
of regulatory affairs jobs in Mumbai. Figures from a
companies and markets.com report show that by the
year 2012 the market for clinical trials in India is
expected to grow to $630 million (£404 million),
helped by the fact that the cost of conducting research
in the country is sometimes less than half that in more
developed nations.[45] The United Arab Emirates
(UAE) is another country looking to expand its appeal
to the pharmaceutical industry, increasing the number
of pharma regulatory affairs jobs in Dubai. A report
by RNCOS suggests that compound annual growth of
17 per cent will take place between 2010 and 2013
and that the UAE is ripe for investment for
pharmaceutical manufacturing operations.
Makes a Good Regulatory Affair Professional -
Most regulatory professionals are graduates in a
scientific discipline, commonly life sciences or
pharmacy, although increasingly biotechnology based
degrees are valuable. Some choose tohave an
additional legal qualification. The ability to tackle
data in a wide range of scientific areas and to quickly
grasp new concepts and complex technical
information is vital. Analyzing issues and presenting
both written and oral evidence before a panel of
experts such as scientists, pharmacists, doctors and
lawyers who run the government agencies require
considerable understanding of both legal and
scientific matters.[46] A high degree of sensitivity is
required when proposing and executing the strategy
and tactics needed to obtain marketing approval in a
way which will satisfy the authorities and serve the
best needs of the company. Considerable care must be
exercised if the best possible case is to be presented to
the authorities for the company. It must be done
without obscuring the facts, enabling the authorities
to arrive at a proper and rightful conclusion regarding
safety, efficacy and quality of the product under
application. Regulatory professionals must always
exercise considerable judgment in the practice of their
role. Integrity and the ability to inspire trust and
confidence are valuable attributes. Project
management skills help to achieve the challenging
goals they are set.[47] They can work as part of
multi-disciplinary teams and lead them when
necessary. They can work under pressure and inspire
and motivate others to do the same
Need of Regulatory Affairs in the Pharmacy
Curriculum-
One of the most tightly regulated sectors in the nation
is the research and development of pharmaceutical,
6. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD52279 | Volume – 6 | Issue – 7 | November-December 2022 Page 122
biotechnology, and medical devices. India is
expanding
In the pharmaceutical industry, the need for
specialists in regulatory affairs to meet the present
needs of industries for the international market.
Professionals in regulatory affairs serve as a bridge
between pharmaceutical businesses and international
regulation agencies. They must be knowledgeable
about the legislation, regulations, policies, and
direction provided by the regulatory agencies. The
requirement to incorporate the present the standard's
requirements for the pharmaceutical industry
Pharmaceutical schools' curricula to provide students
with the most recent innovations to benefit the
industry. the current
The need for regulatory education is discussed in the
essay courses offered, instructional resources, courses
available, syllabus contents, and job opportunities in
regulatory affairs.[48] As the pharmaceutical
industries throughout the world are moving ahead
towards becoming more and more competitive, these
are realizing that the real battle of survival lies in
executing the work by understanding the guidelines
related to various activities carried out to give an
assurance that the process is under regulation.
Pharmaceutical Industry, being one of the highly
regulated industries, which are capable of handling
issues related to regulatory affairs in a comprehensive
manner.[49]
Conclusion- Regulatory Affairs Profession believe
the new approach to regulation will eventually be
adopted for all healthcare products as it represents the
best model for delivering new healthcare advances to
market in a reasonable time with acceptable safety.
Most companies, whether they are major
multinational pharmaceutical corporations or small,
innovative biotechnology companies, have specialist
departments of Regulatory affairs professionals and
Regulatory affairs department is constantly evolving
the one which is least impacted during the acquisition
and merger, and also during recession. Due to the
changing resources necessary to fulfill the regulatory
requirements, some companies also choose to
outsource or out task regulatory affairs to external
service providers. In today’s competitive environment
the reduction of the time taken to reach the market is
critical to a product’s and hence within the company’s
for their success and growth. The proper conduct of
its Regulatory Affairs activities is therefore of
considerable economic importance for the company.
REFERENCE:
[1] Regulatory Affairs from Wikipedia, the free
encyclopedia modified [online] 7th April.
Available from
http://en.wikipedia.org/wiki/Regulatory_Affairs
[2] International regulatory affair updates [online]
2005. Available from
http://www.iraup.com/about.php
[3] “Douglas J Pisano and David S. Mantus” ‘Text
book of FDA Regulatory Affairs A Guide for
Prescription Drugs, Medical Devices, and
Biologics’. 2nd edition, August 2008
[4] Topra brought by dimension associates [online]
Available from
http://www.topra.org/careers/what-regulatory-
affairs.
[5] “Douglas J. Pisano and David S. Mantus” ‘Text
book of FDA Regulatory Affairs A Guide for
Prescription Drugs, Medical Devices, and
Biologics’ Second Edition, August 2008
[6] Science career brought by American
association [online] 2011. Available at
http://sciencecareers.sciencemag.org/career_ma
gazine/previous_issues/articles/1999_12_24/no
DOI.12079275980051408699.
[7] Topra brought by dimension associates [online]
available from
http://www.topra.org/careers/what-
regulatoryaffairs.
[8] Training Needs in Regulatory Science for the
Biopharmaceutical Industry,” Nature jobs
Biotechnology, 2001;19(12):1187-1188
[9] “Careers in Regulatory Affairs from
Practitioner to professional,” Nature jobs
Biotechnology, 2002;20(4): 409- 41:
[10] Regulatory Affairs Management [online].
Available from:
http://medind.nic.in/haa/t06/i1/haat07i1p51.
[11] Recent Advancements [online]. Available from
http://en.wikipedia.org/wiki/Regulatory_Affairs
[12] Measurement of Quality [online]. Available
from: http://www.pharmainfo.net/reviews/total-
qualitymanagement-pharmacy-education-
potentials
[13] Careers in regulatory affairs from practitioner
to professional, nature jobs biotechnology,
2001; 20(4): 409- 410
[14] Available online: www.centrewatch.com
[15] Training needs in regulatory sciences for the
biopharmaceutical industry. 2001; 19(12),1187-
1189
7. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD52279 | Volume – 6 | Issue – 7 | November-December 2022 Page 123
[16] Cutting, Thomas. "How to Survive an Audit".
PM Hut. http://www.pmhut.com/how-to-
survive-an-audit.2008;2(4)13-21
[17] Available online:
http://en.wikipedia.org/wiki/Audit"
[18] Available online: http://ezinearticles.com/?10-
Steps-toMaximize-Your-Energy-
Audit&id=3633861
[19] The Fourth Quadrant: A Map of the Limits of
Statistics Nassim Nicholas Taleb an Edge
Original Essay [online]. Available from
http://www.fda.gov/RegulatoryInformation/
Guidances/ucm125067.htm#toc US FDA
Compliance Program Guidance manual
http://www.fda.gov/downloads/ICECI/Complia
nceManuals/RegulatoryProceduresManual/UC
M
[20] Gehl Sampath, Padmashree. ‘India’s
Pharmaceutical Sector in Emerging Strategies
and Global and Local Implications for Access
to Medicines’.2008
[21] OPPI. 2008. Indian Pharmaceutical Industry:
Vision 2015.
[22] Singh, Seema. 2007. ‘Indian Pharma enters the
global arena’. Cell. 128 March 9. Elsevier.
[23] Das, Anjan & Kumar, Subodh. ‘Innovation,
IPR and Public Good’. Express Pharma Pulse.
2008;3(7)16-31
[24] FICCI. 2005. White Paper on ‘Clinical Trials in
India’.
[25] Srivastava DA. Country level report on the
pharmaceutical sector in India’. Report
commissioned by DFID, UK
[26] Central Drugs Standards Control Organization.
(Website: www.cdsco.nic.in).
[27] http://www.medindia.net/indian_health_act/dru
gs-andcosmetics-act-1940-introduction.htm
[28] www.vakilno1.com/bareacts/drugsandcosmetic
sact/drugsan dcosmeticsact.htm
[29] http://www.dancewithshadows.com/pillscribe/c
gmpregulations-in-india-to-be-diluted/
[30] http://www.prescriptiondrug-
info.com/topics/drug-andcosmetic-act/
[31] N. K. Jain, pharmaceutical product
development” edition 3rd, C.B.S publishers
[32] P.P.Sharma “how to practice GMPs” 5th
edition, Vandana publication Pvt. Ltd Delhi
[33] WHO Expert Committee on Specifications for
Pharmaceutical Preparations. Thirty seventh
Report. Geneva, World Health Organization,
2003 (WHO Technical Report Series, No. 908).
[34] Guide to good storage practices for
pharmaceuticals. WHO Expert Committee on
Specifications for Pharmaceutical Preparations.
Thirty seventh Report. Geneva, World Health
Organization, 2003 (WHO Technical Report
Series, No. 908, Annex 9).
[35] WHO Expert Committee on Specifications for
Pharmaceutical Preparations. Thirty-eighth
Report. Geneva, World Health Organization,
2004 (Technical Report Series, No. 917).
[36] Good trade and distribution practices for
pharmaceutical starting materials. WHO Expert
Committee on Specifications for
Pharmaceutical Preparations. Thirty eighth
Report. Geneva, World Health Organization,
2004 (WHO Technical Report Series, No. 917,
Annex 2).
[37] Quality Assurance of Pharmaceuticals. A
compendium of guidelines and related
materials, Volume 1. Geneva, World Health
Organization, 1997.
[38] Quality Assurance of Pharmaceuticals. A
compendium of guidelines and related
materials. Good manufacturing practices and
inspection, Volume 2 (updated version).
Geneva, World Health Organization, 2004.
[39] Marketing Authorization of Pharmaceutical
Products with Special Reference to Multisource
(Generic) Products – A Manual for a Drug
Regulatory Authority. Geneva, World Health
Organization, 1999 (Regulatory Support Series,
No. 5, WHO/DMP/RGS/98.5).
[40] A Model Quality Assurance System for
Prequalification, Procurement, Storage and
Distribution of Pharmaceutical Products.
Geneva, World Health Organization, 2003
(unpublished draft).
[41] Managing Drug Supply. The selection,
procurement, distribution, and use of
pharmaceuticals. Management Sciences for
Health in collaboration with World Health
Organization. 2nd Ed. Connecticut, USA.
Kumarian Press, Inc., 1997.
[42] Guidelines on Good Distribution Practice of
Medicinal Products for Human Use
(94/C63/03). European Agency for Evaluation
8. International Journal of Trend in Scientific Research and Development @ www.ijtsrd.com eISSN: 2456-6470
@ IJTSRD | Unique Paper ID – IJTSRD52279 | Volume – 6 | Issue – 7 | November-December 2022 Page 124
of Medicinal Products. Directive 92/25/EEC of
31 March 1992.
[43] Australian Code of Good Wholesaling Practice
for Therapeutic Goods for Human Use.
Therapeutic Goods Administration, Australia.
November 1991.
[44] Current Good Manufacturing Practice in
Manufacturing, Processing, Packing or Holding
of drugs and Current Good Manufacturing
Practice for Finished Pharmaceuticals. Code of
Federal Regulations Parts 210 and 211. Food
and Drug Administration, USA.
[45] Principles and Guidelines of Good
Manufacturing Practice for Medicinal Products
for Human Use. Commission Directive 2003
794/356/EEC, 13 June 1991. European Agency
for Evaluation of Medicinal Product
[46] Guidance Document: Good Manufacturing
Practice for Medicine in South Africa.
Medicines Control Council, South Africa,
2003.
[47] Guide to Good Manufacturing Practices for
Medicinal Products. Pharmaceutical Inspection
Convention, Pharmaceutical Inspection Co-
operation Scheme, July 2004.
[48] Guide to Good Manufacturing Practices for
Medicinal Products. Pharmaceutical Inspection
Convention, Pharmaceutical Inspection Co-
operation Scheme, July 2004.
[49] Loan G. M., Wafai Z A., Qadrie Z L., Zargar S
A., A review on “Therapeutic drug monitoring
in psychiatry: an important step in clinical
practice”